Emkay initiated coverage on Dabur India and InCred also initiated coverage on the EMS industry.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
CLSA on Vedanta: Outperform| Target Rs 230
CLSA upgraded Vedanta to outperform from underperform earlier but slashed the target to Rs 230 from Rs 255.
The global investment bank believes that operationally nothing will change in the near term owing to the proposed demerger.
The move will enable the parent to bring strategic investors into these entities and hence ease the debt burden.
For a sustained re-rating, the focus needs to shift back to operating improvements.The upgrade follows a sharp underperformance in the stock price.
CLSA on HUL: Buy| Target Rs 3135
CLSA upgraded HUL to buy from outperform earlier and raised the target price to Rs 3135 from Rs 2925 earlier.
The worst is behind rural demand, and the global investment bank expects a recovery in H2.
The current pain points to ease in the medium term. The valuations appear reasonable, well below the past 5-year median.
The global investment bank upgrades the stock to buy, and positive commentary could be a catalyst.
Emkay on Dabur: Buy| Target Rs 650
Emkay initiated coverage with a buy rating on Dabur with a target price of Rs 650.
The domestic business is likely to recover in the rural region and vigor in International endures.
Premiumization thrust to aid margin. The valuations seem balanced, and better earnings to facilitate stock returns.
InCred on EMS industry: Avalon Technologies, Endurance Technologies
India’s EMS industry is likely to post 32% CAGR to touch $80 billion by CY26. India may become the most attractive country for EMS.
The China +1 strategy augurs well for India. The government policies provide the necessary impetus.
InCred initiated coverage on Avalon Technologies with an ADD rating and a target price of Rs 750. Amber Technologies also has an ADD rating and a target price of Rs 3760.
The brokerage firm initiates coverage on PG Electroplast with an ADD rating and a target price of Rs 2200. Kaynes has a target of Rs 2800.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price